Pfizer-BioNTech and Moderna vaccines effective against COVID-19-associated hospitalizations among adults
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 16 to 20, 2021. This …
COVID-19 Immune Response Appears Strong in Cancer Patients
Vast majority show seropositivity four months after the second COVID-19 vaccine dose
Risk for Myocarditis in Young Who Get Moderna Shots May Be Greater Than Thought
However, health officials emphasize that COVID-19 puts someone at much greater risk for heart inflammation than getting the vaccine does
Decision on J&J COVID-19 Vaccine Booster Doses Could Take Weeks
Federal health officials are waiting on results from a government-backed clinical trial and from studies by Johnson & Johnson
Almost 140,000 COVID-19 Deaths Averted With Vaccinations
Vaccination-associated reduction in deaths translated to statistical life benefit ranging from $625 billion to $1.4 trillion
Biden Puts Pressure on Nursing Homes to Vaccinate Staff Against COVID-19
New mandate, which will come in the form of a regulation to be issued by CMS, could happen next month
COVID-19 Vaccine Effectiveness Down Against New Infections in New York
Recent decline in vaccine effectiveness against new COVID-19 cases coincided with increasing circulation of delta variant
Experts Support COVID-19 Vaccine Booster Shots
Public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement today on the Administration’s plan for COVID-19 booster shots for Americans.
This statement is excerpted below:
“The COVID-19 vaccines authorized in the USA continue to be remarkably effective in reducing the risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant.
Antibiotic Dispensing Decreased After COVID-19 Restrictions
36 percent reduction seen in antibiotic dispensing after COVID-19 restrictions; large reduction found in antibiotics for RTIs